General
Preferred name
ELACRIDAR
Synonyms
GG918 ()
GW0918 ()
GW120918 ()
GF120918 ()
ELACRIDAR HYDROCHLORIDE ()
GF120918A ()
Elacridar (hydrochloride) ()
Elacridar (GF120918) ()
GW120918, GG918, GW0918 ()
LY-335979 ()
LY335979 ()
GF 120918A ()
Elacridar hcl ()
GF-120918A ()
P&D ID
PD008694
CAS
143664-11-3
143851-98-3
178436-75-4
Tags
available
drug candidate
Drug indication
Antineoplastic (adjunct)
Solid tumour/cancer
Drug Status
investigational
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Potent and selective KCC2 inhibitor
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
2
Organisms
0
Compound Sets
14
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugMAP
DrugMatrix
Guide to Pharmacology
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
50
Molecular Weight
563.24
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
6
Aromatic Ring Count
5
cLogP
5.56
TPSA
92.89
Fraction CSP3
0.24
Chiral centers
0.0
Largest ring
6.0
QED
0.24
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Membrane Transporter/Ion Channel
Neuroscience
Target
P-gp?(P-glycoprotein)
ABCB1
P-gp inhibitor
BCRP
P-glycoprotein
P-gp
Primary Target
Multidrug Transporters
MOA
Inhibitor
P glycoprotein inhibitor
Source data